Pharmacoepidemiology and drug safety

Keyphrases

Publications

2023

Wenbo Huang, Masashi Nagao, Naohiro Yonemoto, Sen Guo, Takeshi Tanigawa, Yuji Nishizaki
Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials (CDM-J). Pharmacoepidemiology and drug safety (2023)
Juan M Hincapie-Castillo, Amie J Goodin
Using Joinpoint regression for drug utilization research: Tutorial and case study of prescription opioid use in the United States. Pharmacoepidemiology and drug safety (2023)
Katrin Kurvits, Maia Uusküla, Helve Vestman, Ott Laius
Outpatient fluoroquinolone use in relation to European Medicines Agency's recommendation: An Estonian nationwide drug utilization study. Pharmacoepidemiology and drug safety (2023)
Sara Karami, Adebola Ajao, Jennie Wong, Di Zhang, Tamra Meyer, Yulan Ding, Alex Secora, Jacqueline M Major, Rajdeep Gill, Grace P Chai, Yueqin Zhao, Jana McAninch
The Impact of Hydrocodone Rescheduling on Utilization, Abuse, Misuse, and Overdose Deaths. Pharmacoepidemiology and drug safety (2023)
Xabier Garcia-Albeniz, Pär Stattin, Marcus Westerberg, Rachel Weinrib, Per Sandstrom, Zdravko Vassilev
Design Considerations for Observational Studies of Drugs for Advanced Cancer. Pharmacoepidemiology and drug safety (2023)
Pilar Hernandez-Con, Justine Shults, Allison W Willis, Yu-Xiao Yang
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiology and drug safety (2023)
Stephan Lanes, Daniel C Beachler
Validation to Correct for Outcome Misclassification Bias. Pharmacoepidemiology and drug safety (2023)
Jungyeon Choi, Olaf M Dekkers, Saskia le Cessie
Tying research question and analytical strategy when variables are affected by medication use. Pharmacoepidemiology and drug safety (2023)
Sara Karami, Adebola Ajao, Jennie Wong, Di Zhang, Tamra Meyer, Yulan Ding, Alex Secora, Jacqueline M Major, Rajdeep Gill, Grace P Chai, Yueqin Zhao, Jana McAninch
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths. Pharmacoepidemiology and drug safety (2023)
Omar Mansour, Sonia Hernandez-Diaz, Diego F Wyszynski
mRNA COVID-19 Vaccination Early in Pregnancy and the Risk of Spontaneous Abortion in an International Pregnancy Registry. Pharmacoepidemiology and drug safety (2023)
Elpida Kontsioti, Simon Maskell, Munir Pirmohamed
Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: the case of drug-drug interactions. Pharmacoepidemiology and drug safety (2023)
Brendan F Day, David Menschik, Deborah Thompson, Christopher Jankosky, John Su, Pedro Moro, Craig Zinderman, Kerry Welsh, Rositsa B Dimova, Narayan Nair
Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021. Pharmacoepidemiology and drug safety (2023)
Juan M Hincapie-Castillo, Amie Goodin
Using Joinpoint Regression for Drug Utilization Research: Tutorial and Case Study of Prescription Opioid Use in the United States. Pharmacoepidemiology and drug safety (2023)
Stephan Lanes, Daniel C Beachler
Validation to correct for outcome misclassification bias. Pharmacoepidemiology and drug safety (2023)
Timothy J Savage, Hanna Wardell, Krista F Huybrechts
Accuracy of identifying pediatric acute bacterial sinusitis diagnoses in outpatient claims data. Pharmacoepidemiology and drug safety (2023)
Pilar Hernandez-Con, Justine Shults, Allison W Willis, Yu-Xiao Yang
Dopamine Agonists and Risk of Lung Cancer in Patients with Restless Legs Syndrome. Pharmacoepidemiology and drug safety (2023)
Alecia Clary, Nancy D Lin, Tamar Lasky, Matthew W Reynolds, Anand Chokkalingam, Carla Rodriguez-Watson
Considerations for Defining Medication Exposure When Analyzing Real-World Data. Pharmacoepidemiology and drug safety (2023)
Scott Martin Vouri, Earl J Morris, Marta G Walsh, Jessica Agalliu, Alyssa Dempsey, Leonie Hochleitner, Matthew R Muschett, Stephan Schmidt, Carl J Pepine, Steven M Smith
High-throughput screening for prescribing cascades among real world statin initiators. Pharmacoepidemiology and drug safety (2023)
Giuseppe Roberto, Olga Paoletti, Sara Ferraro, Giulia Hyeraci, Massimo Franchini, Rosa Gini, Daniele Focosi, Marco Tuccori
Cases of acquired hemophilia A following COVID-19 vaccines: cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy. Pharmacoepidemiology and drug safety (2023)
Mikkel Zöllner Ankarfeldt, Benedikte Irene von Osmanski, Kim Blond
Kill your darlings: Stop using the terms retrospective and prospective. Pharmacoepidemiology and drug safety (2023)
Meghna Jani, Belay Birlie Yimer, David Selby, Mark Lunt, Goran Nenadic, William G Dixon
"Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Pharmacoepidemiology and drug safety (2023)
Ankarfeldt Mikkel Zöllner, Benedikte Irene von Osmanski, Blond Kim
Kill your darlings: Stop using the terms retrospective and prospective. Pharmacoepidemiology and drug safety (2023)
Annie Druet-Cabanac, Laurence Sophie Jouaville, Reza Afshari, Rachid Sahnoun, Germain Kouao-Kanga, Massoud Toussi, Denis Granados
A drug utilization study of thiocolchicoside-containing medicinal products for systemic use in France and Italy: A cross-sectional electronic medical records database study. Pharmacoepidemiology and drug safety (2023)
Hemin Lee, Jeffrey A Sparks, Su Been Lee, Kazuki Yoshida, Joan E Landon, Seoyoung C Kim
Validation of Serostatus of Rheumatoid Arthritis Using ICD-10 Codes in Administrative Claims Data. Pharmacoepidemiology and drug safety (2023)
M D X van der Boom, R van Eekeren, Florence P A M van Hunsel
Observed-over-Expected analysis as additional method for pharmacovigilance signal detection in large-scaled spontaneous adverse event reporting. Pharmacoepidemiology and drug safety (2023)
Hemin Lee, Jeffrey A Sparks, Su Been Lee, Kazuki Yoshida, Joan E Landon, Seoyoung C Kim
Validation of Serostatus of Rheumatoid Arthritis Using ICD-10 Codes in Administrative Claims Data. Pharmacoepidemiology and drug safety (2023)
Yue-Ton Huang, Tiffaney Wei, Ya-Ling Huang, Yu-Pu Wu, K Arnold Chan
Validation of diagnosis codes in healthcare databases in Taiwan, a literature review. Pharmacoepidemiology and drug safety (2023)
Omar Mansour, Sonia Hernandez-Diaz, Diego F Wyszynski
mRNA COVID-19 vaccination early in pregnancy and the risk of spontaneous abortion in an international pregnancy registry. Pharmacoepidemiology and drug safety (2023)
Viktor H Ahlqvist, Paul Madley-Dowd, Amanda Ly, Jessica Rast, Michael Lundberg, Egill Jónsson-Bachmann, Daniel Berglind, Dheeraj Rai, Cecilia Magnusson, Brian K Lee
Bias amplification of unobserved confounding in pharmacoepidemiological studies using indication-based sampling. Pharmacoepidemiology and drug safety (2023)
Nam Kyung Je, Sangsu Youm, Pusoon Chun
Real world co-prescribing contraindicated drugs with fluconazole and itraconazole. Pharmacoepidemiology and drug safety (2023)
Brendan F Day, David Menschik, Deborah Thompson, Christopher Jankosky, John Su, Pedro Moro, Craig Zinderman, Kerry Welsh, Rositsa B Dimova, Narayan Nair
Reporting rates for VAERS death reports following COVID-19 vaccination, December 14, 2020-November 17, 2021. Pharmacoepidemiology and drug safety (2023)
Wenbo Huang, Masashi Nagao, Naohiro Yonemoto, Sen Guo, Takeshi Tanigawa, Yuji Nishizaki
Evaluation of the Efficacy and Safety of Romosozumab (Evenity) for the Treatment of Osteoporotic Vertebral Compression Fracture in Postmenopausal Women: A Systematic Review and Meta-analysis of Randomized Controlled Trials (CDM-J). Pharmacoepidemiology and drug safety (2023)
Hemin Lee, Jeffrey A Sparks, Su Been Lee, Kazuki Yoshida, Joan E Landon, Seoyoung C Kim
Validation of serostatus of rheumatoid arthritis using ICD-10 codes in administrative claims data. Pharmacoepidemiology and drug safety (2023)
Linda C Hendriksen, P D van der Linden, R M C Herings, B H Stricker, L E Visser
Women on diuretics have a higher risk of hospital admission because of hyponatremia than men. Pharmacoepidemiology and drug safety (2023)
Pilar Hernandez-Con, Justine Shults, Allison W Willis, Yu-Xiao Yang
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiology and drug safety (2023)
Teng-Chou Chen, Björn Wettermark, Douglas Steinke, Gillian E Caughey, Mina Tadrous, Veronika J Wirtz, Li-Chia Chen, null null
Feasibility and validity of using healthcare databases to conduct cross-national comparative studies of opioid use, its determinants and consequences. Pharmacoepidemiology and drug safety (2023)
Jungyeon Choi, Olaf M Dekkers, Saskia Le Cessie
Tying research question and analytical strategy when variables are affected by medication use. Pharmacoepidemiology and drug safety (2023)
Linda C Hendriksen, Paul D van der Linden, Ron M C Herings, Bruno H Stricker, Loes E Visser
Women on diuretics have a higher risk of hospital admission because of hyponatremia than men. Pharmacoepidemiology and drug safety (2023)
Meghna Jani, Belay Birlie Yimer, David A Selby, Mark Lunt, Goran Nenadic, William Gregory Dixon
"Take up to eight tablets per day": Incorporating free-text medication instructions into a transparent and reproducible process for preparing drug exposure data for pharmacoepidemiology. Pharmacoepidemiology and drug safety (2023)
Galia Zacay, Anthony D Heymann
Intra-articular and soft-tissue corticosteroid injections and risk of infections: population-based self-controlled-risk-interval design. Pharmacoepidemiology and drug safety (2023)
Galia Zacay, Anthony D Heymann
Intra-articular and soft-tissue corticosteroid injections and risk of infections: Population-based self-controlled-risk-interval design. Pharmacoepidemiology and drug safety (2023)
Meiwen D X van der Boom, Rike van Eekeren, Florence P A M van Hunsel
Observed-over-Expected analysis as additional method for pharmacovigilance signal detection in large-scaled spontaneous adverse event reporting. Pharmacoepidemiology and drug safety (2023)
Sarah C Fisher, Meredith M Howley, Emmy L Tran, Elizabeth C Ailes, Eleni A Papadopoulos, Wendy N Nembhard, Marilyn L Browne, null null
Maternal Cyclobenzaprine Exposure and Risk of Birth Defects in the National Birth Defects Prevention Study (1997-2011) and Birth Defects Study to Evaluate Pregnancy Exposures (2014-2018). Pharmacoepidemiology and drug safety (2023)
Bastien Bourrion, Henri Panjo, Mathilde François, Nathalie Pelletier-Fleury
Trends in clomiphene citrate and gonadotropins use in women with infertility between 2010 and 2017: a population-based study in France. Pharmacoepidemiology and drug safety (2023)
Scott Martin Vouri, Earl J Morris, Marta Walsh, Jessica Agalliu, Alyssa Dempsey, Leonie Hochleitner, Matthew R Muschett, Stephan Schmidt, Carl J Pepine, Steven M Smith
High-throughput Screening for Prescribing Cascades among Real World Statin Initiators. Pharmacoepidemiology and drug safety (2023)

volume 32, number 3, 2023

volume 32, number 4, 2023

Mikkel Zöllner Ankarfeldt, Benedikte Irene von Osmanski, Kim Blond
Kill your darlings: Stop using the terms retrospective and prospective. Pharmacoepidemiology and drug safety 32 (4) (2023)
Mikkel Zöllner Ankarfeldt, Benedikte Irene von Osmanski, Kim Blond
Kill your darlings: Stop using the terms retrospective and prospective. Pharmacoepidemiology and drug safety 32 (4) (2023)